BCAP31 and Decreased liver function: Individuals who have deletions encompassing SLC6A8, BCAP31, and ABCD1 are known to be associated with dystonia, profound intellectual disability, liver dysfunction, SNHL, and early death that are more severe than the symptoms observed in patients with isolated intragenic BCAP31 mutations (1, 5–8).